Status:
UNKNOWN
Sexual Health in Patients With Hematologic Malignancies
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Sexuality
Sexual Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sexual wellbeing is an integral component of psychosocial and physical wellbeing. Cancer-related symptoms, treatment side-effects and psychosocial distress have significant impact on sexual well-being...
Detailed Description
1. Introduction As the survival rates for hematologic malignancies improves there is subsequently an increased need for addressing long-term complications. The evidence highlight that patients experie...
Eligibility Criteria
Inclusion
- Patients (age\>18 years) with a hematologic malignancy who is planned to undergo an HSCT, who provide informed written consent and can understand, speak and read Danish are eligible to participate.
Exclusion
- The exclusion criteria include patients with dementia, psychotic disorders, or other cognitive diseases or conditions that hinder participation.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05222282
Start Date
May 1 2022
End Date
January 1 2025
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kristina Nørskov
Copenhagen, Denmark, 1234